Comparing Routine HIV and Hepatitis C Virus Screening to Estimate the Effect of Required Consent on HIV Screening Rates Among Hospitalized Patients.
HCV screening
HIV screening
consent
routine screening
Journal
Public health reports (Washington, D.C. : 1974)
ISSN: 1468-2877
Titre abrégé: Public Health Rep
Pays: United States
ID NLM: 9716844
Informations de publication
Date de publication:
Historique:
pubmed:
7
3
2021
medline:
11
2
2022
entrez:
6
3
2021
Statut:
ppublish
Résumé
Routine screening for HIV and hepatitis C virus (HCV) among specified age cohorts is recommended. New York State requires consent before screening for HIV but not HCV. We sought to estimate the effect of the consent requirement on screening rates for HIV. We performed a retrospective study of patients hospitalized in 2015-2016 at a tertiary care hospital in the Bronx, New York, during a period when prompts in the electronic health record facilitated screening for HIV and HCV among specified age cohorts. We compared proportions of patients eligible for screening for HIV and/or HCV who underwent screening and used generalized estimating equations and a meta-analytic weighted average to estimate an adjusted risk difference between undergoing HIV screening and undergoing HCV screening. Among 11 938 hospitalized patients eligible for HIV and/or HCV screening, 38.5% underwent screening for HIV and 59.1% underwent screening for HCV. The difference in screening rates persisted after adjusting for patient and admission characteristics (adjusted risk difference = 22.0%; 95% CI, 20.6%-23.4%). Whereas the requirement for consent was the only difference in the processes of screening for HIV compared with screening for HCV, differences in how the 2 viruses are perceived may also have contributed to the difference in screening rates. Nevertheless, our findings suggest that requiring consent continues to impede progress toward the public health goal of routine HIV screening.
Identifiants
pubmed: 33673778
doi: 10.1177/0033354921999170
pmc: PMC8721757
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
102-109Subventions
Organisme : NIMH NIH HHS
ID : K23 MH106386
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI124414
Pays : United States
Références
J Acquir Immune Defic Syndr. 2017 May 1;75(1):27-34
pubmed: 28141780
J Emerg Trauma Shock. 2019 Jul-Sep;12(3):185-191
pubmed: 31543641
J Acquir Immune Defic Syndr. 2015 Jan 1;68 Suppl 1:S15-20
pubmed: 25545489
Epidemiol Infect. 2018 Sep;146(12):1537-1542
pubmed: 29932040
BMJ. 2016 Jan 19;532:h6895
pubmed: 26786744
J Acquir Immune Defic Syndr. 2015 Jan 1;68 Suppl 1:S10-4
pubmed: 25545488
Am J Public Health. 2017 Aug;107(8):1259-1265
pubmed: 28640673
Medicine (Baltimore). 2020 Jan;99(2):e18525
pubmed: 31914025
Am J Public Health. 2009 Jun;99(6):1087-92
pubmed: 19372514
Am J Prev Med. 2009 Jul;37(1):57-63
pubmed: 19423271
PLoS One. 2008 Jul 02;3(7):e2591
pubmed: 18596933
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
J Acquir Immune Defic Syndr. 2015 Jan 1;68 Suppl 1:S5-9
pubmed: 25545494
HIV Med. 2012 Aug;13(7):439-43
pubmed: 22413920
MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4
pubmed: 16988643
MMWR Recomm Rep. 2012 Aug 17;61(RR-4):1-32
pubmed: 22895429